TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
08 02 2021
Historique:
received: 22 01 2020
accepted: 16 12 2020
pubmed: 23 12 2020
medline: 29 5 2021
entrez: 22 12 2020
Statut: epublish

Résumé

Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory properties (i.e., the ability to proliferate and generate secondary effector cells) is a key feature of exhaustion; little is known, however, about how these properties are regulated in human virus-specific CD8+ T cells. We found that virus-specific CD8+ T cells from humans and nonhuman primates naturally controlling HIV/SIV infection express more of the transcription factor TCF-1 than noncontrollers. HIV-specific CD8+ T cell TCF-1 expression correlated with memory marker expression and expansion capacity and declined with antigenic stimulation. CRISPR-Cas9 editing of TCF-1 in human primary T cells demonstrated a direct role in regulating expansion capacity. Collectively, these data suggest that TCF-1 contributes to the regulation of the stem-like memory property of secondary expansion capacity of HIV-specific CD8+ T cells, and they provide a rationale for exploring the enhancement of this pathway in T cell-based therapeutic strategies for HIV.

Identifiants

pubmed: 33351785
pii: 136648
doi: 10.1172/jci.insight.136648
pmc: PMC7934879
doi:
pii:

Substances chimiques

HIV Antigens 0
T Cell Transcription Factor 1 0
TCF7 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI116368
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001872
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007618
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI060530
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI069994
Pays : United States
Organisme : NIH HHS
ID : P51 OD011104
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI067039
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM117901
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150449
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NIAID NIH HHS
ID : P50 AI150476
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI134327
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI145806
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI110271
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD074511
Pays : United States

Références

J Immunol. 2006 Dec 1;177(11):7515-9
pubmed: 17114419
J Virol. 2015 Sep;89(17):8677-86
pubmed: 26063417
PLoS Pathog. 2014 Sep 25;10(9):e1004380
pubmed: 25255144
J Virol. 2015 Dec 16;90(6):2718-28
pubmed: 26676775
Immunity. 2014 Dec 18;41(6):1001-12
pubmed: 25526311
J Immunol. 2012 Apr 15;188(8):3859-68
pubmed: 22492686
J Infect Dis. 2019 Sep 13;220(8):1325-1334
pubmed: 31219150
Cell Rep. 2017 Dec 19;21(12):3458-3470
pubmed: 29262326
Blood Adv. 2018 Jul 24;2(14):1685-1690
pubmed: 30021780
J Immunol. 2012 Sep 15;189(6):2722-6
pubmed: 22875805
Eur J Immunol. 2001 Mar;31(3):677-86
pubmed: 11241270
Immunity. 2008 Dec 19;29(6):1009-21
pubmed: 19062316
Front Immunol. 2019 Mar 07;10:400
pubmed: 30899267
Front Immunol. 2017 Sep 29;8:1241
pubmed: 29085360
Nat Commun. 2017 May 03;8:15050
pubmed: 28466857
J Exp Med. 2004 Dec 6;200(11):1407-17
pubmed: 15583014
Trends Immunol. 2019 Dec;40(12):1149-1162
pubmed: 31734149
Cell. 2018 Nov 1;175(4):998-1013.e20
pubmed: 30388456
Annu Rev Immunol. 2019 Apr 26;37:457-495
pubmed: 30676822
Sci Transl Med. 2019 Oct 23;11(515):
pubmed: 31645454
J Virol. 1994 Sep;68(9):6103-10
pubmed: 8057491
J Virol. 2016 Nov 28;90(24):11168-11180
pubmed: 27707919
J Virol. 2015 Aug;89(15):7829-40
pubmed: 25995260
Nat Immunol. 2019 Mar;20(3):326-336
pubmed: 30778252
PLoS Pathog. 2012;8(8):e1002840
pubmed: 22916009
Immunity. 2010 Aug 27;33(2):229-40
pubmed: 20727791
Immunity. 2019 Nov 19;51(5):840-855.e5
pubmed: 31606264
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9777-82
pubmed: 20457902
Curr Opin HIV AIDS. 2014 Sep;9(5):439-45
pubmed: 25010894
Nat Biotechnol. 2020 Jan;38(1):44-49
pubmed: 31819258
Blood. 2013 Jan 31;121(5):801-11
pubmed: 23233659
Gut. 2019 May;68(5):905-915
pubmed: 30622109
Immunity. 2019 Jan 15;50(1):195-211.e10
pubmed: 30635237
Curr Opin Virol. 2019 Oct;38:21-30
pubmed: 31132749
Nat Med. 2009 Jul;15(7):808-13
pubmed: 19525962
J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):211-219
pubmed: 31513075
Immunity. 2007 Sep;27(3):406-16
pubmed: 17892849
J Virol. 2014 Feb;88(3):1819-24
pubmed: 24227857
J Virol. 2009 Nov;83(22):11876-89
pubmed: 19726501
PLoS Pathog. 2013 Feb;9(2):e1003195
pubmed: 23468632
Nat Med. 2010 Oct;16(10):1147-51
pubmed: 20890291
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14658-63
pubmed: 26553974
Science. 2010 Dec 10;330(6010):1551-7
pubmed: 21051598
J Clin Invest. 2020 Feb 3;130(2):789-798
pubmed: 31661461
J Infect Dis. 2015 Nov 1;212(9):1376-86
pubmed: 25883386
AIDS. 2016 Jun 19;30(10):1553-62
pubmed: 26854811
Cancer Immunol Res. 2016 Sep 2;4(9):734-43
pubmed: 27354337
Front Immunol. 2018 Jan 25;9:20
pubmed: 29422894
Front Immunol. 2019 Sep 10;10:2109
pubmed: 31552045
Immunity. 2016 Aug 16;45(2):415-27
pubmed: 27533016
Nat Immunol. 2016 Oct;17(10):1187-96
pubmed: 27487330
Immunol Cell Biol. 2019 Aug;97(7):664-674
pubmed: 31009109
Nature. 2006 Sep 21;443(7109):350-4
pubmed: 16921384
Sci Transl Med. 2019 Dec 18;11(523):
pubmed: 31852798
Gastroenterology. 2019 May;156(6):1805-1819.e9
pubmed: 30664876
Nat Protoc. 2019 Jan;14(1):1-27
pubmed: 30559373
Nat Med. 2006 Oct;12(10):1198-202
pubmed: 16917489
Curr Protoc Immunol. 2009 Apr;Chapter 7:Unit7.1
pubmed: 19347849
Sci Transl Med. 2017 Feb 15;9(377):
pubmed: 28202771
J Immunol. 2014 Dec 1;193(11):5480-7
pubmed: 25355919
J Exp Med. 2003 Nov 3;198(9):1369-80
pubmed: 14581610
Sci Immunol. 2018 Jun 1;3(24):
pubmed: 29858286
Science. 2007 Aug 17;317(5840):944-7
pubmed: 17641165
Nature. 1995 Mar 2;374(6517):70-4
pubmed: 7870176
Immunity. 2015 Sep 15;43(3):591-604
pubmed: 26362266
J Immunol. 2014 Dec 1;193(11):5613-25
pubmed: 25362178
Blood. 2011 May 5;117(18):4805-15
pubmed: 21398582
Nat Immunol. 2002 Nov;3(11):1061-8
pubmed: 12368910
Cell. 2020 Apr 30;181(3):728-744.e21
pubmed: 32302591
J Immunol. 2010 Feb 1;184(3):1191-9
pubmed: 20026746
Nature. 2016 Sep 15;537(7620):417-421
pubmed: 27501248
Immunity. 1998 Jan;8(1):11-20
pubmed: 9462507
Nature. 2018 Jul;559(7714):405-409
pubmed: 29995861
J Clin Invest. 2016 Feb;126(2):455-63
pubmed: 26731469
J Immunol Methods. 2007 Sep 30;326(1-2):93-115
pubmed: 17707394
PLoS Pathog. 2016 Jan 07;12(1):e1005349
pubmed: 26741490
Blood. 2006 Jun 15;107(12):4781-9
pubmed: 16467198
Science. 2012 Nov 30;338(6111):1220-5
pubmed: 23197535
Front Immunol. 2019 Feb 26;10:291
pubmed: 30863403
J Immunol. 2006 Feb 1;176(3):1439-46
pubmed: 16424171
PLoS One. 2008;3(10):e3577
pubmed: 18974782
Immunity. 2018 Feb 20;48(2):243-257.e10
pubmed: 29466756
J Virol. 2012 Jun;86(12):6959-69
pubmed: 22514340
Sci Immunol. 2016 Dec 23;1(6):
pubmed: 28018990
Mucosal Immunol. 2017 Jul;10(4):1008-1020
pubmed: 27827375
J Immunol. 2003 Oct 1;171(7):3837-46
pubmed: 14500685
Sci Immunol. 2020 Jul 3;5(49):
pubmed: 32620560

Auteurs

Rachel L Rutishauser (RL)

Department of Medicine, UCSF, San Francisco, California, USA.

Christian Deo T Deguit (CDT)

Department of Medicine, UCSF, San Francisco, California, USA.
Institute of Human Genetics, University of the Philippines-National Institutes of Health, Manila, Philippines.

Joseph Hiatt (J)

Department of Microbiology and Immunology.
Medical Scientist Training Program.
Biomedical Sciences Graduate Program, and.

Franziska Blaeschke (F)

Department of Microbiology and Immunology.
Diabetes Center, UCSF, San Francisco, California, USA.
Innovative Genomics Institute, University of California, Berkeley, Berkeley, California, USA.

Theodore L Roth (TL)

Department of Microbiology and Immunology.
Medical Scientist Training Program.
Biomedical Sciences Graduate Program, and.

Lynn Wang (L)

Department of Medicine, UCSF, San Francisco, California, USA.

Kyle A Raymond (KA)

Vitalant Research Institute, San Francisco, California, USA.
Department of Laboratory Medicine, UCSF, California, USA.

Carly E Starke (CE)

Barrier Immunity Section, Laboratory of Viral Diseases and.

Joseph C Mudd (JC)

Barrier Immunity Section, Laboratory of Viral Diseases and.

Wenxuan Chen (W)

Department of Medicine, UCSF, San Francisco, California, USA.

Carolyn Smullin (C)

Department of Medicine, UCSF, San Francisco, California, USA.

Rodrigo Matus-Nicodemos (R)

Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.

Rebecca Hoh (R)

Department of Medicine, UCSF, San Francisco, California, USA.

Melissa Krone (M)

Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.

Frederick M Hecht (FM)

Department of Medicine, UCSF, San Francisco, California, USA.

Christopher D Pilcher (CD)

Department of Medicine, UCSF, San Francisco, California, USA.

Jeffrey N Martin (JN)

Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.

Richard A Koup (RA)

Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , NIH, Bethesda, Maryland, USA.

Daniel C Douek (DC)

Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.

Jason M Brenchley (JM)

Barrier Immunity Section, Laboratory of Viral Diseases and.

Rafick-Pierre Sékaly (RP)

Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.

Satish K Pillai (SK)

Vitalant Research Institute, San Francisco, California, USA.
Department of Laboratory Medicine, UCSF, California, USA.

Alexander Marson (A)

Department of Medicine, UCSF, San Francisco, California, USA.
Department of Microbiology and Immunology.
Diabetes Center, UCSF, San Francisco, California, USA.
Innovative Genomics Institute, University of California, Berkeley, Berkeley, California, USA.
Chan Zuckerberg Biohub, San Francisco, California, USA.
UCSF Hellen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.
Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.

Steven G Deeks (SG)

Department of Medicine, UCSF, San Francisco, California, USA.

Joseph M McCune (JM)

Department of Medicine, UCSF, San Francisco, California, USA.

Peter W Hunt (PW)

Department of Medicine, UCSF, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH